Industry: Food & Beverages
Published Date: 2024-09-01
Pages: 112 Pages
Report ld: 3306703
Request Sample
Customized Report
Stage 2 Infant Formula Market Size(US$)

CAGR 2024-2030
6.7%
Market Size,2030
USD 30,210
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
The global Stage 2 Infant Formula market was valued at US$ 19110 million in 2023 and is anticipated to reach US$ 30210 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
North American market for Stage 2 Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Stage 2 Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Stage 2 Infant Formula include Mead Johnson, Nestle, Danone, Abbott, FrieslandCampina, Heinz, Bellamy, Topfer, HiPP, Perrigo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Stage 2 Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stage 2 Infant Formula.
The Stage 2 Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stage 2 Infant Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stage 2 Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Stage 2 Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Stage 2 Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Stage 2 Infant Formula Market Overview
1.1 Product Definition
1.2 Stage 2 Infant Formula by Type
1.2.1 Global Stage 2 Infant Formula Market Value Comparison by Type (2024-2030)
1.2.2 Conventional
1.2.3 Organic
1.3 Stage 2 Infant Formula by Application
1.3.1 Global Stage 2 Infant Formula Market Value by Application (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Stage 2 Infant Formula Market Size Estimates and Forecasts
1.4.1 Global Stage 2 Infant Formula Revenue 2019-2030
1.4.2 Global Stage 2 Infant Formula Sales 2019-2030
1.4.3 Global Stage 2 Infant Formula Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Stage 2 Infant Formula Market Competition by Manufacturers
2.1 Global Stage 2 Infant Formula Sales Market Share by Manufacturers (2019-2024)
2.2 Global Stage 2 Infant Formula Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Stage 2 Infant Formula Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Stage 2 Infant Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Stage 2 Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Stage 2 Infant Formula, Product Type & Application
2.7 Global Key Manufacturers of Stage 2 Infant Formula, Date of Enter into This Industry
2.8 Global Stage 2 Infant Formula Market Competitive Situation and Trends
2.8.1 Global Stage 2 Infant Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Stage 2 Infant Formula Players Market Share by Revenue
2.8.3 Global Stage 2 Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Stage 2 Infant Formula Market Scenario by Region
3.1 Global Stage 2 Infant Formula Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Stage 2 Infant Formula Sales by Region: 2019-2030
3.2.1 Global Stage 2 Infant Formula Sales by Region: 2019-2024
3.2.2 Global Stage 2 Infant Formula Sales by Region: 2025-2030
3.3 Global Stage 2 Infant Formula Revenue by Region: 2019-2030
3.3.1 Global Stage 2 Infant Formula Revenue by Region: 2019-2024
3.3.2 Global Stage 2 Infant Formula Revenue by Region: 2025-2030
3.4 North America Stage 2 Infant Formula Market Facts & Figures by Country
3.4.1 North America Stage 2 Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Stage 2 Infant Formula Sales by Country (2019-2030)
3.4.3 North America Stage 2 Infant Formula Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Stage 2 Infant Formula Market Facts & Figures by Country
3.5.1 Europe Stage 2 Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Stage 2 Infant Formula Sales by Country (2019-2030)
3.5.3 Europe Stage 2 Infant Formula Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Stage 2 Infant Formula Market Facts & Figures by Region
3.6.1 Asia Pacific Stage 2 Infant Formula Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Stage 2 Infant Formula Sales by Region (2019-2030)
3.6.3 Asia Pacific Stage 2 Infant Formula Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Stage 2 Infant Formula Market Facts & Figures by Country
3.7.1 Latin America Stage 2 Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Stage 2 Infant Formula Sales by Country (2019-2030)
3.7.3 Latin America Stage 2 Infant Formula Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Stage 2 Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa Stage 2 Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Stage 2 Infant Formula Sales by Country (2019-2030)
3.8.3 Middle East and Africa Stage 2 Infant Formula Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Stage 2 Infant Formula Sales by Type (2019-2030)
4.1.1 Global Stage 2 Infant Formula Sales by Type (2019-2024)
4.1.2 Global Stage 2 Infant Formula Sales by Type (2025-2030)
4.1.3 Global Stage 2 Infant Formula Sales Market Share by Type (2019-2030)
4.2 Global Stage 2 Infant Formula Revenue by Type (2019-2030)
4.2.1 Global Stage 2 Infant Formula Revenue by Type (2019-2024)
4.2.2 Global Stage 2 Infant Formula Revenue by Type (2025-2030)
4.2.3 Global Stage 2 Infant Formula Revenue Market Share by Type (2019-2030)
4.3 Global Stage 2 Infant Formula Price by Type (2019-2030)
5 Segment by Application
5.1 Global Stage 2 Infant Formula Sales by Application (2019-2030)
5.1.1 Global Stage 2 Infant Formula Sales by Application (2019-2024)
5.1.2 Global Stage 2 Infant Formula Sales by Application (2025-2030)
5.1.3 Global Stage 2 Infant Formula Sales Market Share by Application (2019-2030)
5.2 Global Stage 2 Infant Formula Revenue by Application (2019-2030)
5.2.1 Global Stage 2 Infant Formula Revenue by Application (2019-2024)
5.2.2 Global Stage 2 Infant Formula Revenue by Application (2025-2030)
5.2.3 Global Stage 2 Infant Formula Revenue Market Share by Application (2019-2030)
5.3 Global Stage 2 Infant Formula Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mead Johnson
6.1.1 Mead Johnson Company Information
6.1.2 Mead Johnson Description and Business Overview
6.1.3 Mead Johnson Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mead Johnson Stage 2 Infant Formula Product Portfolio
6.1.5 Mead Johnson Recent Developments/Updates
6.2 Nestle
6.2.1 Nestle Company Information
6.2.2 Nestle Description and Business Overview
6.2.3 Nestle Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nestle Stage 2 Infant Formula Product Portfolio
6.2.5 Nestle Recent Developments/Updates
6.3 Danone
6.3.1 Danone Company Information
6.3.2 Danone Description and Business Overview
6.3.3 Danone Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Danone Stage 2 Infant Formula Product Portfolio
6.3.5 Danone Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Company Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Stage 2 Infant Formula Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 FrieslandCampina
6.5.1 FrieslandCampina Company Information
6.5.2 FrieslandCampina Description and Business Overview
6.5.3 FrieslandCampina Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.5.4 FrieslandCampina Stage 2 Infant Formula Product Portfolio
6.5.5 FrieslandCampina Recent Developments/Updates
6.6 Heinz
6.6.1 Heinz Company Information
6.6.2 Heinz Description and Business Overview
6.6.3 Heinz Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Heinz Stage 2 Infant Formula Product Portfolio
6.6.5 Heinz Recent Developments/Updates
6.7 Bellamy
6.7.1 Bellamy Company Information
6.7.2 Bellamy Description and Business Overview
6.7.3 Bellamy Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Bellamy Stage 2 Infant Formula Product Portfolio
6.7.5 Bellamy Recent Developments/Updates
6.8 Topfer
6.8.1 Topfer Company Information
6.8.2 Topfer Description and Business Overview
6.8.3 Topfer Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Topfer Stage 2 Infant Formula Product Portfolio
6.8.5 Topfer Recent Developments/Updates
6.9 HiPP
6.9.1 HiPP Company Information
6.9.2 HiPP Description and Business Overview
6.9.3 HiPP Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.9.4 HiPP Stage 2 Infant Formula Product Portfolio
6.9.5 HiPP Recent Developments/Updates
6.10 Perrigo
6.10.1 Perrigo Company Information
6.10.2 Perrigo Description and Business Overview
6.10.3 Perrigo Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Perrigo Stage 2 Infant Formula Product Portfolio
6.10.5 Perrigo Recent Developments/Updates
6.11 Arla
6.11.1 Arla Company Information
6.11.2 Arla Description and Business Overview
6.11.3 Arla Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Arla Stage 2 Infant Formula Product Portfolio
6.11.5 Arla Recent Developments/Updates
6.12 Holle
6.12.1 Holle Company Information
6.12.2 Holle Description and Business Overview
6.12.3 Holle Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Holle Stage 2 Infant Formula Product Portfolio
6.12.5 Holle Recent Developments/Updates
6.13 Meiji
6.13.1 Meiji Company Information
6.13.2 Meiji Description and Business Overview
6.13.3 Meiji Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Meiji Stage 2 Infant Formula Product Portfolio
6.13.5 Meiji Recent Developments/Updates
6.14 Biostime
6.14.1 Biostime Company Information
6.14.2 Biostime Description and Business Overview
6.14.3 Biostime Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Biostime Stage 2 Infant Formula Product Portfolio
6.14.5 Biostime Recent Developments/Updates
6.15 China Feihe
6.15.1 China Feihe Company Information
6.15.2 China Feihe Description and Business Overview
6.15.3 China Feihe Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.15.4 China Feihe Stage 2 Infant Formula Product Portfolio
6.15.5 China Feihe Recent Developments/Updates
6.16 Junlebao Dairy
6.16.1 Junlebao Dairy Company Information
6.16.2 Junlebao Dairy Description and Business Overview
6.16.3 Junlebao Dairy Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Junlebao Dairy Stage 2 Infant Formula Product Portfolio
6.16.5 Junlebao Dairy Recent Developments/Updates
6.17 Ausnutria Dairy
6.17.1 Ausnutria Dairy Company Information
6.17.2 Ausnutria Dairy Description and Business Overview
6.17.3 Ausnutria Dairy Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Ausnutria Dairy Stage 2 Infant Formula Product Portfolio
6.17.5 Ausnutria Dairy Recent Developments/Updates
6.18 Yili Group
6.18.1 Yili Group Company Information
6.18.2 Yili Group Description and Business Overview
6.18.3 Yili Group Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Yili Group Stage 2 Infant Formula Product Portfolio
6.18.5 Yili Group Recent Developments/Updates
6.19 Synutra
6.19.1 Synutra Company Information
6.19.2 Synutra Description and Business Overview
6.19.3 Synutra Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Synutra Stage 2 Infant Formula Product Portfolio
6.19.5 Synutra Recent Developments/Updates
6.20 Beingmate
6.20.1 Beingmate Company Information
6.20.2 Beingmate Description and Business Overview
6.20.3 Beingmate Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Beingmate Stage 2 Infant Formula Product Portfolio
6.20.5 Beingmate Recent Developments/Updates
6.21 Yashili
6.21.1 Yashili Company Information
6.21.2 Yashili Description and Business Overview
6.21.3 Yashili Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Yashili Stage 2 Infant Formula Product Portfolio
6.21.5 Yashili Recent Developments/Updates
6.22 Bright Dairy
6.22.1 Bright Dairy Company Information
6.22.2 Bright Dairy Description and Business Overview
6.22.3 Bright Dairy Stage 2 Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Bright Dairy Stage 2 Infant Formula Product Portfolio
6.22.5 Bright Dairy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Stage 2 Infant Formula Industry Chain Analysis
7.2 Stage 2 Infant Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Stage 2 Infant Formula Production Mode & Process
7.4 Stage 2 Infant Formula Sales and Marketing
7.4.1 Stage 2 Infant Formula Sales Channels
7.4.2 Stage 2 Infant Formula Distributors
7.5 Stage 2 Infant Formula Customers
8 Stage 2 Infant Formula Market Dynamics
8.1 Stage 2 Infant Formula Industry Trends
8.2 Stage 2 Infant Formula Market Drivers
8.3 Stage 2 Infant Formula Market Challenges
8.4 Stage 2 Infant Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Stage 2 Infant Formula market is projected to grow from US$ 21710 million in 2025 to US$ 33970 million by 2032, at a CAGR of 6.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 190
USD 4900.00
(Single User License)
The global Stage 2 Infant Formula market size was US$ 21710 million in 2025 and is forecast to reach a readjusted size of US$ 33970 million by 2032 with a CAGR of 6.7% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 114
USD 4250.00
(Single User License)
The global market for Stage 2 Infant Formula was estimated to be worth US$ 21710 million in 2025 and is projected to reach US$ 33970 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 154
USD 3950.00
(Single User License)
The global Stage 2 Infant Formula market was valued at US$ 21710 million in 2025 and is anticipated to reach US$ 33970 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 139
USD 2900.00
(Single User License)
The global Stage 2 Infant Formula market is projected to grow from US$ 20480 million in 2024 to US$ 32040 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 189
USD 4900.00
(Single User License)
The global Stage 2 Infant Formula market size was US$ 20480 million in 2024 and is forecast to a readjusted size of US$ 32040 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 113
USD 4250.00
(Single User License)
The global market for Stage 2 Infant Formula was estimated to be worth US$ 20480 million in 2024 and is forecast to a readjusted size of US$ 32040 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 166
USD 3950.00
(Single User License)
The global market for Stage 2 Infant Formula was valued at US$ 20480 million in the year 2024 and is projected to reach a revised size of US$ 32040 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-03-13
Pages: 110
USD 2900.00
(Single User License)
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published Date: 2024-09-01
Pages: 175
USD 4350.00
(Single User License)
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published Date: 2024-09-01
Pages: 191
USD 4900.00
(Single User License)
The global Stage 2 Infant Formula market is projected to grow from US$ 21710 million in 2025 to US$ 33970 million by 2032, at a CAGR of 6.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 190
The global Stage 2 Infant Formula market size was US$ 21710 million in 2025 and is forecast to reach a readjusted size of US$ 33970 million by 2032 with a CAGR of 6.7% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 114
The global market for Stage 2 Infant Formula was estimated to be worth US$ 21710 million in 2025 and is projected to reach US$ 33970 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-01-09
Pages: 154
The global Stage 2 Infant Formula market was valued at US$ 21710 million in 2025 and is anticipated to reach US$ 33970 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-01-09
Pages: 139
The global Stage 2 Infant Formula market is projected to grow from US$ 20480 million in 2024 to US$ 32040 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 189
The global Stage 2 Infant Formula market size was US$ 20480 million in 2024 and is forecast to a readjusted size of US$ 32040 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 113
The global market for Stage 2 Infant Formula was estimated to be worth US$ 20480 million in 2024 and is forecast to a readjusted size of US$ 32040 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 166
The global market for Stage 2 Infant Formula was valued at US$ 20480 million in the year 2024 and is projected to reach a revised size of US$ 32040 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-03-13
Pages: 110
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published: 2024-09-01
Pages: 175
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published: 2024-09-01
Pages: 191
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now